文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

因即将接受体外受精而对女性输卵管疾病进行的手术治疗。

Surgical treatment for tubal disease in women due to undergo in vitro fertilisation.

作者信息

Johnson Neil, van Voorst Sabine, Sowter Martin C, Strandell Annika, Mol Ben Willem J

机构信息

Department of Obstetrics & Gynaecology, University of Auckland, PO Box 92019, Auckland, New Zealand, 1003.

出版信息

Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD002125. doi: 10.1002/14651858.CD002125.pub3.


DOI:10.1002/14651858.CD002125.pub3
PMID:20091531
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7154223/
Abstract

BACKGROUND: Tubal disease, and particularly hydrosalpinx, has a detrimental effect on the outcome of in-vitro fertilisation (IVF). Performing a surgical intervention such as salpingectomy, tubal occlusion, aspiration of the hydrosalpinx fluid, or salpingostomy, prior to the IVF procedure in women with hydrosalpinges is thought improve the likelihood of successful outcome. OBJECTIVES: To assess and compare the value of surgical treatments for tubal disease prior to IVF. SEARCH STRATEGY: Trials were sought in the Cochrane Menstrual Disorders and Subfertility Group trials register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, PSYCHMED and in Conference proceedings and reference lists up until Ocober 28 2009. Researchers in the field were contacted to reveal unpublished studies. SELECTION CRITERIA: All trials comparing a surgical treatment for tubal disease with a control group generated by randomisation were considered for inclusion in the review. DATA COLLECTION AND ANALYSIS: Two reviewers independently assessed trial quality and extracted data. The studied outcomes were live birth, ongoing pregnancy, viable-, clinical- and biochemical pregnancy, ectopic pregnancy, miscarriage, multiple pregnancy, ovarian function and complications. MAIN RESULTS: Five randomised controlled trials involving 646 women were included in this review. Four studies assessed salpingectomy versus no treatment, two of which also included a tubal occlusion arm, and one trial assessed aspiration versus no treatment. No trials reported on the primary outcome: live birth. The odds of ongoing pregnancy (Peto OR 2.14, 95%CI 1.23 to 3.73) and of clinical pregnancy (Peto OR 2.31, 95%CI 1.48 to 3.62) however were increased with laparoscopic salpingectomy for hydrosalpinges prior to IVF. Laparoscopic occlusion of the fallopian tube versus no intervention did not increase the odds of ongoing pregnancy significantly (Peto OR 7.24, 95%CI 0.87 to 59.57) but the odds of clinical pregnancy (Peto OR 4.66, 95%CI 2.47 to 10.01) had sufficient power to show a significant increase. Comparison of tubal occlusion to salpingectomy did not show a significant advantage of either surgical procedure in terms of ongoing pregnancy (Peto OR: 1.65, 95%CI 0.74, 3.71) or clinical pregnancy (Peto OR 1.28, 95%CI 0,76 to 2.14). One RCT reported efficacy of ultrasound guided aspiration, however the odds of pregnancy did not show a significant increase in the odds of clinical pregnancy (Peto OR 1.97, 95%CI 0.62 to 6.29), and confidence intervals were wide. Throughout the different comparisons no significant differences were seen in adverse effects of surgical treatments. AUTHORS' CONCLUSIONS: Surgical treatment should be considered for all women with hydrosalpinges prior to IVF treatment. Previous evidence supported only unilateral salpingectomy for a unilateral hydrosalpinx (bilateral salpingectomy for bilateral hydrosalpinges). This review now provides evidence that laparoscopic tubal occlusion is an alternative to laparoscopic salpingectomy in improving IVF pregnancy rates in women with hydrosalpinges. Further research is required to assess the value of aspiration of hydrosalpinges prior to or during IVF procedures and also the value of tubal restorative surgery as an alternative (or as a preliminary) to IVF.

摘要

背景:输卵管疾病,尤其是输卵管积水,对体外受精(IVF)的结局有不利影响。对于患有输卵管积水的女性,在IVF手术前进行手术干预,如输卵管切除术、输卵管阻塞术、输卵管积水抽吸术或输卵管造口术,被认为可以提高成功受孕的可能性。 目的:评估和比较IVF前输卵管疾病手术治疗的价值。 检索策略:在Cochrane月经紊乱与不育症研究组试验注册库、Cochrane对照试验中央注册库(CENTRAL)、MEDLINE、EMBASE、PSYCHMED以及会议论文集和参考文献列表中检索截至2009年10月28日的试验。联系该领域的研究人员以获取未发表的研究。 入选标准:所有比较输卵管疾病手术治疗与随机分组产生的对照组的试验均被考虑纳入本综述。 数据收集与分析:两名评价员独立评估试验质量并提取数据。研究的结局包括活产、持续妊娠、可存活妊娠、临床妊娠和生化妊娠、异位妊娠、流产、多胎妊娠、卵巢功能和并发症。 主要结果:本综述纳入了5项涉及646名女性的随机对照试验。4项研究评估了输卵管切除术与不治疗的效果,其中2项还包括输卵管阻塞组,1项试验评估了抽吸术与不治疗的效果。没有试验报告主要结局:活产。然而,对于IVF前因输卵管积水行腹腔镜输卵管切除术的患者,持续妊娠(Peto比值比2.14,95%可信区间1.23至3.73)和临床妊娠(Peto比值比2.31,95%可信区间1.48至3.62)的几率增加。输卵管腹腔镜阻塞术与不干预相比,持续妊娠几率未显著增加(Peto比值比7.24,95%可信区间0.87至59.57),但临床妊娠几率(Peto比值比4.66,95%可信区间2.47至10.01)有足够的检验效能显示显著增加。输卵管阻塞术与输卵管切除术相比,在持续妊娠(Peto比值比:1.65,95%可信区间0.74,3.71)或临床妊娠(Peto比值比1.28,95%可信区间0.76至2.14)方面,两种手术方法均未显示出显著优势。一项随机对照试验报告了超声引导下抽吸术的疗效,然而临床妊娠几率未显示出显著增加(Peto比值比1.97,95%可信区间0.62至6.29),且可信区间较宽。在所有不同的比较中,手术治疗的不良反应未见显著差异。 作者结论:对于所有IVF治疗前患有输卵管积水的女性均应考虑手术治疗。既往证据仅支持单侧输卵管积水行单侧输卵管切除术(双侧输卵管积水行双侧输卵管切除术)。本综述现提供证据表明,在提高输卵管积水女性的IVF妊娠率方面,腹腔镜输卵管阻塞术是腹腔镜输卵管切除术的一种替代方法。需要进一步研究评估IVF手术前或手术期间输卵管积水抽吸术的价值,以及输卵管修复手术作为IVF替代方法(或作为初步治疗)的价值。

相似文献

[1]
Surgical treatment for tubal disease in women due to undergo in vitro fertilisation.

Cochrane Database Syst Rev. 2010-1-20

[2]
Surgical treatment for tubal disease in women due to undergo in vitro fertilisation.

Cochrane Database Syst Rev. 2004

[3]
Surgical treatment for tubal disease in women due to undergo in vitro fertilisation.

Cochrane Database Syst Rev. 2001

[4]
Surgical treatment for tubal disease in women due to undergo in vitro fertilisation.

Cochrane Database Syst Rev. 2020-10-22

[5]
In vitro fertilisation for unexplained subfertility.

Cochrane Database Syst Rev. 2005-4-18

[6]
Tubal flushing for subfertility.

Cochrane Database Syst Rev. 2005-4-18

[7]
Techniques for pelvic surgery in subfertility.

Cochrane Database Syst Rev. 2006-4-19

[8]
Luteal phase support for assisted reproduction cycles.

Cochrane Database Syst Rev. 2011-10-5

[9]
Volume expanders for the prevention of ovarian hyperstimulation syndrome.

Cochrane Database Syst Rev. 2016-8-31

[10]
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).

Cochrane Database Syst Rev. 2018-2-1

引用本文的文献

[1]
Progesterone signaling in oviductal epithelial cells modulates the immune response to support preimplantation embryonic development.

Sci Adv. 2025-4-18

[2]
Investigation of the female genital tract microbiome and its association with hydrosalpinx in women undergoing salpingectomy.

Arch Gynecol Obstet. 2025-6

[3]
Pregnancy outcomes after all modes of conception in patients with genital tuberculosis: a systematic review and meta-analysis.

Obstet Gynecol Sci. 2025-3

[4]
Unveiling the Promise: A Comprehensive Review of Salpingectomy as a Vanguard for Ovarian Cancer Prevention.

Cureus. 2024-1-28

[5]
The time interval between laparoscopic tubal ligation and frozen-thawed embryo transfer does not affect the reproductive outcomes.

BMC Pregnancy Childbirth. 2023-8-3

[6]
Transvaginal Ultrasound Accuracy in the Hydrosalpinx Diagnosis: A Systematic Review and Meta-Analysis.

Diagnostics (Basel). 2023-3-2

[7]
Unilateral Partial Absence of the Fallopian Tube in a Female Patient With Infertility: A Case Report and Literature Review.

Cureus. 2022-12-28

[8]
The influence of timing of oocytes retrieval and embryo transfer on the IVF-ET outcomes in patients having bilateral salpingectomy due to bilateral hydrosalpinx.

Front Surg. 2023-1-5

[9]
Female Genital Tuberculosis: Clinical Presentation, Current Diagnosis, and Treatment.

Infect Dis Obstet Gynecol. 2022

[10]
A comprehensive analysis of miRNA/isomiRs profile of hydrosalpinx patients with interventional ultrasound sclerotherapy.

PLoS One. 2022

本文引用的文献

[1]
Measuring outcomes in fertility trials: can we rely on clinical pregnancy rates?

Fertil Steril. 2010-1-13

[2]
The ESEP study: salpingostomy versus salpingectomy for tubal ectopic pregnancy; the impact on future fertility: a randomised controlled trial.

BMC Womens Health. 2008-6-26

[3]
Ultrasound-guided hydrosalpinx aspiration during oocyte collection improves pregnancy outcome in IVF: a randomized controlled trial.

Hum Reprod. 2008-5

[4]
Is there a role for hysteroscopic tubal occlusion of functionless hydrosalpinges prior to IVF/ICSI in modern practice?

Acta Obstet Gynecol Scand. 2007

[5]
Proximal tubal occlusion and salpingectomy result in similar improvement in in vitro fertilization outcome in patients with hydrosalpinx.

Fertil Steril. 2006-12

[6]
Management of hydrosalpinx before or during in vitro fertilization-embryo transfer: a national postal survey in France.

Fertil Steril. 2006-10

[7]
Evidence of improving quality of reporting of randomized controlled trials in subfertility.

Hum Reprod. 2006-10

[8]
Pregnancy outcome in patients with early recurrent abortion following laparoscopic tubal corneal interruption of a fallopian tube with hydrosalpinx.

Fertil Steril. 2006-7

[9]
Ovarian response to gonadotropins after laparoscopic salpingectomy or the division of fallopian tubes for hydrosalpinges.

Fertil Steril. 2006-5

[10]
Proximal occlusion of hydrosalpinx by hysteroscopic placement of microinsert before in vitro fertilization-embryo transfer.

Fertil Steril. 2005-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索